BidaskClub upgraded shares of LHC Group (NASDAQ:LHCG) from a strong sell rating to a sell rating in a research note issued to investors on Wednesday morning.

LHCG has been the topic of a number of other reports. Oppenheimer upped their target price on shares of LHC Group from $68.00 to $80.00 and gave the stock an outperform rating in a research note on Tuesday, November 7th. Jefferies Group upped their target price on shares of LHC Group from $68.00 to $83.00 and gave the stock a buy rating in a research note on Tuesday, November 7th. They noted that the move was a valuation call. Zacks Investment Research upgraded shares of LHC Group from a sell rating to a hold rating in a research note on Wednesday, January 31st. Robert W. Baird set a $71.00 target price on shares of LHC Group and gave the stock a hold rating in a research note on Tuesday, November 28th. Finally, SunTrust Banks restated a buy rating and issued a $75.00 target price on shares of LHC Group in a research note on Friday, November 3rd. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and nine have issued a buy rating to the stock. The stock currently has a consensus rating of Buy and a consensus price target of $77.10.

LHC Group (NASDAQ:LHCG) opened at $63.56 on Wednesday. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.77 and a quick ratio of 1.77. The company has a market cap of $1,140.98, a PE ratio of 27.40, a price-to-earnings-growth ratio of 1.67 and a beta of 0.71. LHC Group has a one year low of $46.18 and a one year high of $76.14.

Several institutional investors and hedge funds have recently made changes to their positions in the company. Arrowstreet Capital Limited Partnership lifted its position in shares of LHC Group by 194.5% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 64,500 shares of the health services provider’s stock worth $3,951,000 after purchasing an additional 42,600 shares during the period. Rhumbline Advisers lifted its position in shares of LHC Group by 16.5% in the 4th quarter. Rhumbline Advisers now owns 38,021 shares of the health services provider’s stock worth $2,329,000 after purchasing an additional 5,371 shares during the period. Arizona State Retirement System lifted its position in shares of LHC Group by 224.8% in the 4th quarter. Arizona State Retirement System now owns 27,342 shares of the health services provider’s stock worth $1,675,000 after purchasing an additional 18,924 shares during the period. Capital Fund Management S.A. purchased a new stake in shares of LHC Group in the 4th quarter worth approximately $355,000. Finally, Pinebridge Investments L.P. lifted its position in shares of LHC Group by 64.2% in the 4th quarter. Pinebridge Investments L.P. now owns 30,624 shares of the health services provider’s stock worth $1,875,000 after purchasing an additional 11,971 shares during the period. 85.74% of the stock is owned by hedge funds and other institutional investors.

WARNING: This article was originally reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this article on another site, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The legal version of this article can be read at https://theolympiareport.com/2018/02/11/lhc-group-lhcg-stock-rating-upgraded-by-bidaskclub.html.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.